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Abstract
Since the identification of CD39 and other members of the e-NTPDase (ecto-nucleoside triphosphate diphosphohy-
drolase) family as the primary enzymes responsible for cell surface nucleotide hydrolysis, one of their most intriguing
features has been their unusual topology. The active site lies in the large extracellular region, but instead of being
anchored in the membrane by a single transmembrane domain or lipid link like other ectoenzymes, CD39 has two
transmembrane domains, one at each end. In this review we discuss evidence that the structure and dynamics of the
transmembrane helices are intricately connected to enzymatic function. Removal of either or both transmembrane
domains or disruption of their native state by detergent solubilization reduces activity by 90%, indicating that native
function requires both transmembrane domains to be present and in the membrane. Enzymatic and mutational analysis
of the native and truncated forms has shown that the active site can exist in distinct functional states characterized by
different total activities, substrate specificities, hydrolysis mechanisms, and intermediate ADP release during ATP
hydrolysis, depending on the state of the transmembrane domains. Disulfide crosslinking of cysteines introduced within
the transmembrane helices revealed that they interact within and between molecules, in particular near the extracellular
domain, and that activity depends on their organization. Both helices exhibit a high degree of rotational mobility, and
the ability to undergo dynamic motions is required for activity and regulated by substrate binding. Recent reports
suggest that membrane composition can regulate NTPDase activity. We propose that mechanical bilayer properties,
potentially elasticity, might regulate CD39 by altering the balance between stability and mobility of its transmembrane
domains.
Abbreviations: e-NTPDase –ecto-nucleoside triphosphate diphosphohydrolase; ACR–apyrase conserved region; TM1–
transmembrane domain 1; TM2–transmembrane domain 2
While the existence of divalent cation dependent nucleo-
tidase activities on the outer surface of the plasma
membrane of animal cells has been known for over 50
years [1, 2], the molecular identification of the relevant
proteins began in 1996 when potato apyrase, an enzyme
with properties similar to those of the plasma membrane
nucleotidases, was cloned [3]. Several members of this
class of proteins have since been cloned [4Y8]. All family
members share a set of short sequences termed apyrase
conserved regions (ACRs), and the mammalian family
members are collectively referred to as ecto-nucleoside
triphosphate diphosphohydrolases (e-NTPDases). Of the
eight members of this family, all have two transmembrane
domains except for NTPDases 5 and 6. NTPDase1 is
CD39. NTPDases 1, 2, 3 and 8 are located in the plasma
membrane, while the UDPase and a similar protein cloned
from pancreatic tumor cells, LALP70 [9] both called
NTPDase 4, are in the Golgi membranes and lysosomal
vacuoles. NTPDase 7 is present in intracellular membranes
[7].
Ecto-enzymes, for instance 50-nucleotidase and alkaline
phosphatase, are generally anchored to the membrane by a
single transmembrane domain or lipid link [10]. Why do
the plasma membrane bound NTPDases in animal cells
have two transmembrane domains, one at each end of the
molecule? Most proteins with this structure are channels (K
channels, mechanosensitive channels, purinergic receptors
(P2X) and epithelial Na channels [11]). In this review we
discuss the development of the idea that the transmem-
brane domains of the NTPDases, in additional to simply
anchoring the protein in the membrane, play an integral
role in the function and regulation of the enzymes.
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The original clue to a connection between the transmem-
brane domains and active site function of the cell surface
NTPDases was the loss of activity upon detergent
solubilization. Pre-cloning attempts to study the proteins
by purifying them from native membranes had been
frustrated by the fact that nearly every detergent used for
extraction abolished most of the enzymatic activity [12].
Following the cloning of the soluble potato apyrase [3] and
the subsequent identification of CD39 as the major
membrane bound enzyme responsible for cell surface
apyrase activity [13], two things became apparent. First,
CD39 had the unusual feature of being linked to the
membrane by two transmembrane domains flanking its
extracellular active site [14], in contrast to the lipid link or
single transmembrane domain observed for most other
ecto-enzymes [10]. Second, despite conservation of the
ACRs [3] thought to constitute the nucleotide binding site,
detergent sensitivity was a property of the membrane
bound CD39 but not of the soluble potato apyrase [15]o r
of the related soluble T. gondii NTPases [16]. These two
pieces of information led Wang and Guidotti to ask
whether disruption of transmembrane domain interactions
is the mechanism for detergent effects, and thus whether
the two transmembrane domains are required for enzymatic
activity.
The answer to both questions was yes. Wang et al. [15]
systematically deleted the amino terminal (TM1), carboxy
terminal (TM2) or both transmembrane domains of CD39
and compared the activity and detergent sensitivity of each
truncated protein with native CD39. Truncation of both
transmembrane domains resulted in a catalytically active
secreted soluble protein that, like the naturally occurring
soluble family members, was resistant to detergent.
Furthermore, its activity was about 90% lower than native
CD39 and approximately equal to that of detergent
solubilized CD39. Thus, removal of the transmembrane
domains both mimicked and precluded the detergent effect,
supporting the hypothesis that the transmembrane domains
are required for activity and that detergents disrupt activity
via them rather than by binding to the active site. While
this result left open the possibility that removal from the
membrane might be the crucial factor, the single truncation
versions of CD39 narrowed the focus to structural features
of the transmembrane domains themselves. Deletion of
either TM1 or TM2 resulted in a catalytically active
enzyme that was targeted to and rooted in the plasma
membrane; nevertheless, both proteins were resistant to
detergents and had low enzymatic activity similar to that of
the double truncated enzyme. These studies made clear that
native CD39 activity requires both TM1 and TM2 to be
present and in the membrane.
Wang et al. [15] further proposed that not only the
presence and membrane insertion of the transmembrane
domains but also the interactions between them are
required for native activity. Glutaraldehyde crosslinking
as well as sucrose density gradient sedimentation in the
presence of detergents showed that the protein formed
oligomers, that detergents that reduced activity dissociated
the oligomers, and that the soluble extracellular domain
lacking both transmembrane domains existed only as a
monomer. Furthermore, the one detergent that had only a
small effect on activity, digitonin, preserved oligomers.
Together these data suggested that the transmembrane
domains mediate oligomer formation and might contribute
to enzymatic function by this means. However, the
correlation between oligomerization and native activity
was not exact; both the TM1 and TM2 single truncated
proteins also formed oligomers despite their detergent-
level activity, suggesting that a specific set of interactions
involving both TM1 and TM2 might underlie their
influence on the active site.
While the nature and importance of oligomerization or
of any particular interactions between the transmembrane
domains remained uncertain, the work of Wang et al.
established that understanding the relationship between the
transmembrane domains and the active site was critical to
understanding CD39 function. In the following sections we
discuss first the development of the idea that CD39 can
exist in at least two different functional states characterized
by distinct quantitative and qualitative enzymatic proper-
ties, each with distinct physiological consequences,
depending on the state of its transmembrane domains. We
then discuss experiments and questions concerning what
exactly the transmembrane domains do at the structural and
dynamic level and how they might enable CD39 function
to be regulated by its membrane environment.
Transmembrane domains govern switching
between mechanistically and enzymatically distinct
forms of the active site
The Wang et al. experiments revealed that disrupting the
transmembrane domains significantly reduced the rate of
nucleotide hydrolysis, but due to the high specific activity
of native CD39 the retention of 10% activity still left the
disrupted forms with a respectable enough hydrolysis rate
to be studied in their own right. Through the experiments
described below it has become clear that the disrupted
forms are not simply a weakened version of native CD39.
Not only total activity but also the hydrolysis mechanisms,
role of ACR1, discrimination between substrates, and
presence or absence of intermediate ADP release during
ATP hydrolysis are all at the mercy of the transmembrane
domains. For all cases looked at, the various properties fall
into line one way for native CD39 and the alternative way
for the soluble double truncated, single TM1 and TM2
truncated, and detergent solubilized forms, suggesting that
the active site can exist in two distinct states depending on
the presence or absence of native transmembrane domain
organization.
The insight into these differences originated from
initially transmembrane domain-blind efforts to understand
the hydrolysis mechanism and role of the ACRs of CD39
as well as the basis for the different substrate specificities
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active site had not been determined for any family
members, attention was focused on the five ACRs [3, 17],
particularly on ACR1 and ACR4 due to their homology
with the crystallographically identified phosphate binding
loops of the actin/hsp70/hexokinase superfamily [3, 18].
Mutagenesis of completely conserved residues in these
regions was found to abolish both ATPase and ADPase
activity, consistent with their constituting the active site for
both ATP and ADP hydrolysis [19Y22]. However, ACR
sequence comparisons among family members with differ-
ent substrate specificities, particularly between apyrases
and ATPases, offered no clues to how the enzymes
discriminate between ATP and ADP; in many cases the
ACRs of apyrases and ATPases were identical [16, 23, 24].
On the other hand, the two-transmembrane domain
apyrases and ATPases known at the time did exhibit
conserved sequence differences in their transmembrane
domains [23, 24]. Added to this was the somewhat obscure
fact that two residues in the putative b-phosphate binding
loop ACR1 correlated with the presence or absence of
transmembrane domains [23]. Among the cloned family
members, most of those with two transmembrane domains
had a histidine at the position corresponding to H59 in
CD39 and asparagine, serine, or alanine in the position
corresponding to N61, while all with zero or one
transmembrane domain had glycine/serine and arginine at
these positions. Given the backdrop of the recent discovery
that the transmembrane domains influence active site
function, these two sets of correlations suggested a
potential relationship among the role of ACR1, substrate
specificity, and the contribution of the transmembrane
domains to ATPase and ADPase activities.
Mutation of these ACR1 residues in both native CD39
and its truncated and detergent solubilized versions
revealed not only a point of distinction between ATP and
ADP hydrolysis mechanisms but also that the enzyme uses
different hydrolysis mechanisms depending on the state of
its transmembrane domains [23]. Substituting G or S for
H59 in native CD39 abolished approximately 95% of the
ATPase activity but less than 50% of the ADPase activity
and thus converted CD39 from an apyrase with a 1.4:1
ATPase:ADPase rate ratio to primarily an ADPase with a
6:1 (for H59G) or 8:1 (H59S) ADPase:ATPase ratio.
However, the effect of these substitutions was completely
different in the truncated and solubilized backgrounds.
When introduced into the soluble form of CD39 lacking
both transmembrane domains, H59G and H59S substitution
had no effect whatsoever on ATPase activity and caused a
t w o f o l di n c r e a s ei nA D P a s e activity. The result was
identical for the TM1 and TM2 single truncated forms
and for the detergent solubilized full length protein.
Substitution of N61 with R had a more modest effect on
the ATPase:ADPase ratio, changing it only to a 2:1
ADPase:ATPase ratio, but similarly reduced activity in
the native context and had no effect in the truncated and
solubilized backgrounds. These results were in contrast to
mutation of completely conserved residues in ACR1 as
well as in ACRs 2, 3, and 4, which abolished both ATPase
and ADPase activity in both the native and truncated
contexts [19Y22].
Thus ATP hydrolysis was shown to occur through a
mechanism characterized by a critical dependence on H59
in the native enzyme while occurring through a different
mechanism that completely bypasses this residue when the
transmembrane domains are disrupted. The fact that other
residues in ACR1 were equally critical in both contexts
suggested that the active site does not relocate; instead the
way the substrate is hydrolyzed by the same active site
appeared to change. The same story turned out to be true
for the distinction between ATP and ADP hydrolysis
mechanisms in the native context; while both substrates
use the same active site, ATP was notably more vulnerable
to H59 substitution than was ADP. The fact that the same
residue represented a pivot point distinguishing between
native and non-native ATP hydrolysis mechanisms on one
hand, and between ATP and ADP hydrolysis mechanisms
on the other hand, added up to the conclusion that the
transmembrane domains, at least in part via H59, are
responsible for the distinction between the native ATP and
ADP hydrolysis mechanisms.
This conclusion suggested that the transmembrane
domains might also regulate substrate specificity. Support
for this hypothesis was provided by a set of experiments
comparing CD39 with CD39L1 (NTPDase2), a family
member that like CD39 has two transmembrane domains
and loses about 90% of its activity when solubilized but
which hydrolyzes primarily ATP [25]. Despite their
different substrate specificities in the native state, upon
solubilization or double truncation each enzyme arrived at
an intermediate ATPase:ADPase ratio of 3.5:1. Thus,
removal or disruption of transmembrane domains not only
lowered the activity of both enzymes but removed the
distinction between the apyrase and the ATPase and left
them both with the same intermediate ATPase:ADPase
ratio. This discovery supported the idea that the extracel-
lular domains of the membrane bound apyrase and ATPase
have the same intrinsic substrate specificity and that the
state of their transmembrane domains determines whether
they remain in this basic form or assume their native
identities as an apyrase or ATPase.
Further studies [25] suggested that the key to how the
transmembrane domains bring about this distinction might
be their ability to confer different ADP hydrolysis
mechanisms on the two enzymes. Similarly to CD39,
CD39L1 was found to use different ATP hydrolysis
mechanisms in its native and soluble states. Substituting
H50, the equivalent of H59 in CD39, with G or S reduced
the ATPase activity of native CD39L1 by approximately
90% but had no significant effect on either ATPase or
ADPase activity in CD39L1 solubilized in detergent or
lacking both transmembrane domains. However, unlike in
CD39, in native CD39L1 these substitutions had the same
effect on ADPase activity as on ATPase activity; they
reduced ADPase activity by 90%, so that rather than
changing the enzyme into an ADPase as in CD39, H50
substitution caused no change in native CD39L1 substrate
specificity. These results suggested that while the state of
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between H50/59 dependent and independent ATP hydro-
lysis mechanisms, the native transmembrane domain state
also brings about a difference in ADP hydrolysis mecha-
nisms between the apyrase and the ATPase. While for both
enzymes native transmembrane domain organization
causes an overall increase in ADPase activity relative to
the solubilized state, the native ADP hydrolysis mech-
anism is critically dependent on H50 in CD39L1 but rel-
atively independent of H59 in CD39. Neither enzyme
requires H50/59 for ADP hydrolysis in the solubilized
state. These data suggested that the native transmembrane
state confers the distinct substrate specificities on the
apyrase and ATPase by conferring distinct ADP hydrolysis
mechanisms.
Concurrently with this work on hydrolysis mechanisms
and substrate specificity, it was also discovered that the
transmembrane domains determine whether or not ADP is
released from the active site as an intermediate during
ATP hydrolysis. In all cases CD39 was known to
hydrolyze one phosphate at a time; pyrophosphate was
not released under any circumstances. Nevertheless,
Heine et al. [26] showed that when CD39 hydrolyzed
ATP to completion, an ADP intermediate was never
observed in the process; only a decrease in ATP and a
subsequent increase in AMP occurred. In contrast, Chen
and Guidotti [27] found that soluble CD39 lacking both
TM1 and TM2 did exhibit intermediate ADP release; ATP
disappearance was followed by the appearance of ADP,
which subsequently decreased with a concomitant buildup
of AMP. These data suggested that in native CD39, the
ATP and ADP hydrolysis mechanisms are such that ATP
and ADP hydrolysis can occur in succession without
dissociation of ADP, while in soluble CD39 the two
mechanisms are such that ADP as product must dissociate
and rebind to the active site as substrate. Such a scenario
would be consistent with the above mentioned finding that
the ATP and ADP hydrolysis mechanisms are distin-
guished by their dependence and independence of H59 in
native CD39 but have no such distinction in soluble CD39;
the ability to use the same active site differently may be
key to the ability to hydrolyze ADP without releasing and
rebinding it. Consistent with this idea, Heine et al. [26]
observed an intermediate buildup of ADP prior to
production of AMP with native CD39L1, which, as
described above, has ATP and ADP hydrolysis mecha-
nisms that use H50 to the same extent and may therefore
lack the distinction between ATP and ADP hydrolysis
mechanisms required for successive hydrolysis of both
phosphates.
Mobility of transmembrane helices regulates
and is regulated by the active site
Together, the studies described above revealed that the
answer to several of the physiologically important ques-
tions concerning CD39 Y its total activity, mechanism,
substrate specificity, whether ADP is produced upon ATP
hydrolysis Y is that it depends on the state of the
transmembrane domains. To the extent studied, the case
looks similar for CD39L1 and could potentially apply to
other two transmembrane domain NTPDase family mem-
bers. The question now turns to the transmembrane
domains themselves: What specifically about them is
responsible for their effects on the active site, and,
ultimately, how might they change within the context of
the natural membrane environment and potentially mani-
fest the different forms of the enzyme?
In theory, any of a broad range of structural features
might underlie CD39’s requirement for both TM1 and
TM2 to be present and in the membrane. Independent of
any interactions between them, they might serve to position
the adjacent ends of the extracellular domain at a fixed
distance from the membrane, thus stabilizing the structure
by eliminating one degree of freedom in the direction
perpendicular to the membrane. They might also interact to
limit both the lateral and rotational degrees of freedom of
the ends of the extracellular domain relative to each other.
Either case would be likely to have a direct influence on
the active site, since ACR1 and ACR5 are only about 10 to
20 amino acids from TM1 and TM2, respectively. With or
without intramolecular interactions between TM1 and
TM2, the transmembrane domains might work by stabiliz-
ing oligomers, as proposed by Wang et al. [15]. Oligomer
stabilization might be achieved nonspecifically by reducing
the effective concentration of CD39 molecules by limiting
their movement to the two dimensions of the membrane
rather than the three in solution; if either of the first two
cases is true then specific intermolecular transmembrane
domain interactions would not necessarily have to be
invoked to explain the requirement for both TM1 and TM2.
Alternatively, TM1, TM2, or both might work by interact-
ing intermolecularly in various combinations to produce an
oligomer with a specific orientation of subunits. Such
interactions might occur in the presence or absence of
intramolecular TM1YTM2 interactions.
Most discussion of the role of the transmembrane
domains has revolved around oligomerization due to the
fact that CD39 as well as other family members forms
oligomers in various crosslinking, sedimentation, and
native gel experiments [15, 28, 29]. Nevertheless, the jury
has remained out on whether oligomerization is essential to
native activity because no experiments have been able to
demonstrate a direct causal relationship. Oligomerization
per se does not correlate with native CD39 activity; both
the TM1 and TM2 single truncated constructs [15] as well
as full length CD39 solubilized in cholate form oligomers
but have the same enzymatic properties as soluble CD39,
indicating oligomerization is not sufficient for native
properties. To date no experiment has been able to
distinguish whether oligomerization is necessary for native
activity because all experiments that can be shown to
dissociate oligomers also potentially disrupt intramolec-
ular TM1YTM2 interactions or remove CD39 from the
membrane.
A more comprehensive picture of both intra- and
intermolecular transmembrane domain interactions and
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oxidative crosslinking of cysteines introduced into TM1
and TM2 [30]. The technique is based on the principle that
if cysteines are introduced in pairs, only pairs that are
oriented toward each other and are within the length of a
disulfide bond can form disulfides upon addition of an
oxidizing agent. Since oxidation can occur within the
membrane, CD39 transmembrane domain interactions
were analyzed and correlated with activity and substrate
binding in the native membrane environment.
Crosslinking of cysteines substituted one at a time along
TM1, along TM2, and at various pairs of TM1 and TM2
positions revealed that the transmembrane domains do in
fact interact both within and between CD39 molecules.
Strong intramolecular TM1YTM2 interactions as well as
intermolecular TM1YTM10 and TM2YTM20 interactions
were observed near the extracellular side of the membrane,
with weaker interactions near the cytoplasmic side. This
evidence for transmembrane helix packing, particularly in
the region closest to the active site, supported the idea that
specific interactions might underlie the transmembrane
domains’ role in enzyme function. However, the two
helices turned out to exhibit a high degree of flexibility
concerning which helix faces constituted the interaction
interfaces; under crosslinking conditions used in several
other membrane proteins to identify interacting helix faces
[31Y33], complete disulfide formation occurred between
all faces of TM1 and TM2 within a molecule as well as
between all faces of TM1 and TM10 and TM2 and TM20 of
different molecules. The failure of multiple cysteines per
helix to increase the size of the crosslinked oligomers
ruled out the possibility of a large array of subunits or
of subunits randomly colliding with no specificity. This
result, together with the multiple intramolecular TM1Y
TM2 interfaces, indicated that while the transmembrane
domains do interact, each helix exhibits a high degree of
rotational mobility, presumably within the packed struc-
ture. In nearly all cases TM1YTM2 disulfide formation
precluded TM1YTM10 or TM20YTM20 crosslinking, indi-
cating that even with rotational mobility taken into account,
interactions within a subunit are stronger than those
between subunits.
Despite the high degree of mobility, distinct helix faces
could be discerned by differences in temperature depen-
dence of disulfide formation at different positions. At low
temperatures crosslinking was limited primarily to posi-
tions along one side of each helix, suggesting that the
helices do have specific favored interaction surfaces rather
than complete randomness. However, locking the helices in
this orientation by forming disulfides at the positions most
readily crosslinked at low temperature neither increased
activity nor protected the enzyme from loss of activity in
response to detergent. Rather, crosslinking at any position,
both within and between subunits, resulted in loss of
activity comparable to the loss induced by solubilizing or
by removing the transmembrane domains altogether. Such
was the case for an exhaustive combination of TM1YTM2
pairs representing all combinations of helical faces as well
as a variety of relative depths in the membrane, as well as
for every possible TM1YTM10 and TM2YTM20 linkage
between subunits.
The loss of activity caused by locking the helices in any
single orientation revealed, first, that both intra- and
intermolecular interactions between the transmembrane
domains are a crucial factor in their regulation of active
site function; despite the high degree of mobility, the
enzyme cannot function with its transmembrane domains
in random orientations. At the same time, these results
disfavored the idea that the transmembrane domains work
by stabilizing one optimal orientation; rather the data
suggested that they must be able to move relative to each
other during the process of nucleotide binding and
hydrolysis. Such movements may be necessary within and
between subunits.
Further supporting a relationship between active site and
transmembrane domain dynamics was the observation that
ATP binding regulates transmembrane helix crosslinking.
In the absence of ATP, as described above, all positions
could be crosslinked at physiological temperatures; how-
ever in the presence of ATP crosslinking at physiological
temperature was limited to the same helical pattern seen
without ATP at low temperatures. The effect was mim-
icked by another substrate, ADP, but not by AMP or
phosphate. These results indicated that substrate binding
stabilizes the transmembrane helices in a specific arrange-
ment and thus directly revealed a structural interdepen-
dence between active site and transmembrane domain
structure and dynamics. While the specifics of how exactly
different stages of nucleotide binding and hydrolysis might
correlate with different transmembrane domain arrange-
ments remain to be worked out, these results suggested that
changes in active site structure during the process of
hydrolysis may be tied to changes in transmembrane
domain arrangement.
Thus, in addition to specific interactions between the
transmembrane domains, the ability of the transmembrane
helices to undergo dynamic motions may underlie their
regulation of enzymatic function. In these studies, mobility
itself represents a parameter that can both regulate and be
regulated by the active site. While locking the transmem-
brane helices in place limits mobility, removing or solu-
bilizing them may represent the opposite extreme; lack of
interactions between them may provide too much freedom
to the active site and reduce activity by uncoupling active
site and transmembrane helix movements (Figure 1). The
balance between stability and flexibility may therefore be a
critical feature to examine when asking how the trans-
membrane domains might change in the context of the
native membrane environment to regulate potential shifting
between different states of the enzyme.
Native CD39 may sense bilayer mechanical properties
via its transmembrane helices
While understanding how the transmembrane domains
contribute to activity provides insight into how CD39
CD39 transmembrane domains 395works, it remains unknown to what extent the transmem-
brane helices themselves may be regulated by their
environment. Membrane proteins in general vary in the
extent to which they can be regulated by membrane
context, and the factors that determine how much trans-
membrane helix behavior is determined by intrinsic
sequence properties and how much by the surrounding
lipids are not well understood. To date the question of
whether CD39 can be converted within native cell
membranes to exhibit the mechanistic properties of the
solubilized and truncated forms has not been examined in
detail. However, a recent report provides compelling
evidence that such regulation by membrane environment
may indeed occur. Papanikolaou et al. [34] show that
removing cholesterol from membranes prepared from
CD39-expressing cells reduces ATPase activity to the
same extent as does solubilization. Activity loss is cor-
related with the amount of cholesterol remaining in the
membrane. While the low activity may or may not indicate
the presence of different hydrolysis mechanisms and enzy-
matic properties observed for the solubilized and truncated
forms of CD39, their finding that readdition of cholesterol
to the membrane restores activity indicates that the protein
is not simply denatured.
Regulation of activity by cholesterol content presumably
occurs via changes in the transmembrane domains, but
understanding how they sense cholesterol content and relay
it to the active site requires comparison of their structure
and dynamics in the presence of different amounts of
cholesterol. In addition, examining a broad assortment of
reagents and other means for altering membrane structure
is necessary to gain insight into the mechanical features of
the membrane that underlie such changes. The demonstra-
tion by Papanikolaou et al. [34] that adding cholestenone to
cholesterol depleted membranes does not restore CD39
activity suggests that some aspect of cholesterol other than
its effect on membrane fluidity is required for native
transmembrane helix properties but leaves open the
question of whether cholesterol acts through direct binding
to CD39 or via general changes in membrane properties
other than fluidity.
Recent studies by Mukasa et al. [35] on two related
two transmembrane domain NTPDases, NTPDase2 and 8,
suggest that at least these family members may be reg-
ulated by general properties of the membrane. NTPDase2
activity is decreased by concentrations of NP40 that are
not expected to solubilize it, as well as by high temper-
ature. NTPDase8 activity is resistant to NP40 and increased
by high temperature, but inhibited by the combination
of NP40 and high temperature. Exchanging transmem-
brane domains between the two enzymes demonstrates
that these effects are mediated at least in part via the mem-
brane. While comparisons among family members are
complicated by the fact that they differ in their transmem-
brane domain sequences and detergent sensitivity, these
experiments suggest that NTPDases may be regulated by a
broad array of structurally unrelated membrane perturbing
factors.
Mukasa et al. [35] propose that their results may be
explained by changes in oligomer stability due to changes
in membrane fluidity; however, as discussed above,
fluidity does not explain the effect of cholesterol on
CD39. The different enzymes may sense different features
of the membrane environment. Alternatively, the various
perturbing methods may change a common mechanical
feature other than fluidity. Along these lines, Lundbaek et
al. [36] have identified bilayer elasticity as a membrane
property that is altered by a variety of structurally unrelated
compounds as well as by cholesterol depletion and which
can explain the common effects of all these treatments on
the function of gramicidin and cardiac sodium channel
function. Changes in elasticity change the energy required
for local membrane deformation associated with a protein
conformational change and can therefore modify the total
energy barrier between different transmembrane domain
conformations. If, as proposed above, the balance between
stability and mobility is a key feature of the interplay
between the transmembrane domains and active site of
CD39, anything that changes bilayer elasticity might
change activity by altering this balance. In particular,
changes that increase elasticity, such as detergents and
cholesterol depletion, might increase mobility by lowering
the barriers among different conformations and thus
uncouple transmembrane domain and active site dynamics
as proposed for truncated and solubilized CD39.
Physiologically, extracellular nucleotide concentrations
are directly linked to a number of mechanical and biochem-
ical processes that change the properties of the membrane
(reviewedin[37Y39]). ATP release is a primary response to
Figure 1. Cartoon of the structure of CD39. The region labeled PM
represents the lipid bilayer of the plasma membrane. TM1 and TM2 are
the N-terminal and the C-terminal transmembrane domains, respectively.
The hourglass structures attached to TM1 and TM2 represent ACR1 and
ACR5, respectively; they are part of the extracellular domain of CD39
(cylinder). The dynamic interactions between TM1 and TM2 in wild type
(WT) CD39 may position ACR1 and ACR5 so that the configurations and
mobility of the enzymatic active site are optimal and the specific activity
is maximal. Removal of TM1 (DTM1), TM2 (DTM) or both transmem-
brane domains (DTM1 + DTM2) eliminates the interactions between TM1
and TM2 and would be expected to disrupt the alignment of ACR1 and
ACR5 and of the enzymatic active site to bring about a loss of specific
activity.
396 A. Grinthal & G. Guidottimechanical pressure and shear stress as well as to changes
in osmotic pressure; in the latter case the resulting
extracellular ATP is required to restore osmotic balance.
Inflammatory processes and oxidative stress, both of which
rely on signaling by extracellularnucleotides, trigger release
of unsaturated fatty acids and lysophosphatidylcholine, both
of which can insert in the membrane and change its
curvature and elasticity. High cholesterol levels are associ-
ated with blood clotting, which is modulated by extracellu-
lar nucleotides. In each of these cases the ability to modulate
the hydrolysis rate, substrate specificity, and intermediate
ADP release of CD39 according to the mechanical state of
the membrane would provide a direct feedback mechanism
between cellular conditions that affect the membrane and
the extracellular nucleotide signaling processes that respond
to them. Thus, the presence of two transmembrane domains
might be a key to instantaneously tailoring extracellular
nucleotide signaling to the state of the cell.
Preliminary work suggests that CD39 may have func-
tions beyond apyrase activity, also potentially mediated by
its transmembrane domains. Bodas et al. [40] have shown
that CD39 can act as an ATP channel, while Wu et al. [41]
have found that the short cytoplasmic region of the protein
binds ran binding protein and thus potentially plays a role
in intracellular signaling. If CD39 is confirmed to serve as
a transporter of nucleotides or of signals across the mem-
brane, the structural and dynamic regulation by and of the
two transmembrane domains may underlie an interdepen-
dence among the active site, the bilayer, and the internal
state of the cell.
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